Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin-FMD trial for prevention of endothelial ischemia-reperfusion injury
NL-OMON37620Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started May 2012; status: recruiting.
02
Drugs
metformin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NL-OMON37620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37620.